Dr Reddy’s shares down by 7% as quality issue delays commercial launch of semaglutide
AMN Shares of Dr Reddy’s Laboratories SLUMPED nearly 7% in Thursday’s trade (July 9) on the NSE after the drugmaker said commercial supplies of its semaglutide product would be delayed…

